Literature DB >> 15541838

Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk.

Laurent Argaud1, G Rioufol, M Lièvre, L Bontemps, P Legalery, M Stumpf, G Finet, R Itti, X André-Fouët, M Ovize.   

Abstract

AIMS: It is unclear whether the protection observed in human heart following repetition of brief episodes of ischaemia is due to opening of coronary collaterals or to ischaemic preconditioning. We investigated whether the improvement in ST segment change following repeated episodes of brief ischaemia during coronary angioplasty is due to preconditioning when the size of the area at risk and the collateral flow are taken into account. METHODS AND
RESULTS: Thirty-six patients underwent percutaneous transluminal coronary angioplasty. Intracoronary ST segment changes were measured throughout the procedure and used as an endpoint. The size of the area at risk and the collateral perfusion within the ischaemic bed were measured using single photon emission computerized tomography (SPECT). Mean ST segment shift observed in all patients significantly decreased from 11.0+/-2.6 mm during the first balloon inflation to 8.5+/-2.3 mm during the second inflation. This protective effect occurred in the absence of any change in the size of the area at risk (mean: 46+/-5% of LV) and of the collateral perfusion to the ischaemic zone (mean: 23+/-4% of flow in the non-ischaemic zone).
CONCLUSION: These results suggest that ischaemic preconditioning does occur during repeated brief coronary artery occlusion in the human heart.

Entities:  

Mesh:

Year:  2004        PMID: 15541838     DOI: 10.1016/j.ehj.2004.07.040

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  10 in total

Review 1.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

3.  Acute changes of left ventricular hemodynamics and function during percutaneous coronary intervention in patients with unprotected left main coronary artery disease.

Authors:  Seong-Mi Park; Chul-Min Ahn; Soon-Jun Hong; Yong-Hyun Kim; Jae-Hyoung Park; Wan-Joo Shim; Do-Sun Lim
Journal:  Heart Vessels       Date:  2014-03-15       Impact factor: 2.037

4.  Ischemic Preconditioning and Coronary Collateral Blood Flow Increment: Two Sides of the Same Coin?

Authors:  Elpidio Santillo; Luca Fallavollita; Luciano Marini
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

5.  Myocardial perfusion imaging after transient balloon occlusion during percutaneous coronary interventions.

Authors:  Raed Aqel; Gilbert J Zoghbi; Luvenia W Bender; Johnny W Scott; Jon A Baldwin; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

6.  Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humans.

Authors:  Stephen P Hoole; Paul A White; Philip A Read; Patrick M Heck; Nick E West; Michael O'Sullivan; David P Dutka
Journal:  J Appl Physiol (1985)       Date:  2012-02-09

Review 7.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 8.  Preconditioning in humans.

Authors:  Shereif H Rezkalla; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Influence of preinfarction angina and coronary collateral blood flow on the efficacy of remote ischaemic conditioning in patients with ST segment elevation myocardial infarction: post hoc subgroup analysis of a randomised controlled trial.

Authors:  Kasper Pryds; Morten Bøttcher; Astrid Drivsholm Sloth; Kim Munk; Michael Rahbek Schmidt; Hans Erik Bøtker
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

Review 10.  Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?

Authors:  Petra Kleinbongard; Hans Erik Bøtker; Michel Ovize; Derek J Hausenloy; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.